Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Bilastine | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Bilastine | hsa00052 | Galactose metabolism | 1.06E-03 | 2 | P06280, O43451 | GLA, MGAM | More | | Bilastine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Bilastine | hsa00190 | Oxidative phosphorylation | 8.86E-05 | 3 | Q16718, P36542, O14521 | NDUFA5, ATP5C1, SDHD | More | | Bilastine | hsa00220 | Arginine biosynthesis | 1.21E-02 | 1 | P15104 | GLUL | More | | Bilastine | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Bilastine | hsa00500 | Starch and sucrose metabolism | 1.54E-06 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Bilastine | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Bilastine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Bilastine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Bilastine | hsa00591 | Linoleic acid metabolism | 1.29E-03 | 1 | P11712 | CYP2C9 | More | | Bilastine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 3.93E-06 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Bilastine | hsa00730 | Thiamine metabolism | 2.39E-05 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Bilastine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Bilastine | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Bilastine | hsa00910 | Nitrogen metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | | Bilastine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.09E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Bilastine | hsa00982 | Drug metabolism - cytochrome P450 | 4.09E-04 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Bilastine | hsa00983 | Drug metabolism - other enzymes | 2.02E-03 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Bilastine | hsa01100 | Metabolic pathways | 4.43E-02 | 23 | Q9NR34, P05089, P32320, P22748, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737 | MAN1C1, ARG1, CDA, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL | More | | Bilastine | hsa01230 | Biosynthesis of amino acids | 1.90E-03 | 4 | P60891, Q99707, P15104, P37837 | PRPS1, MTR, GLUL, TALDO1 | More | | Bilastine | hsa01240 | Biosynthesis of cofactors | 2.95E-02 | 2 | P13716, P14618 | ALAD, PKM2 | More | | Bilastine | hsa01522 | Endocrine resistance | 4.74E-02 | 3 | P22694, P10415, Q13323 | PRKACB, BCL2, BIK | More | | Bilastine | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Bilastine | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | | Bilastine | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Bilastine | hsa03010 | Ribosome | 5.85E-04 | 8 | P62753, P25398, P32969, P46776, P62899, P18077, P61927, P36578 | RPS6, RPS12, RPL9, RPL27A, RPL31, RPL35A, RPL37, RPL4 | More | | Bilastine | hsa03013 | RNA transport | 7.99E-12 | 24 | O14980, P52298, Q09161, O14893, P61326, Q15287, Q9UBU9, Q7Z3B4, P35658, P63279, P68104, P47813, Q14152, P55884, O15371, O75822, P11940, P20042, Q14240, Q9BZI7, P23588, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, RNPS1, NXF1, NUP54, NUP214, UBE2I, EEF1A1, EIF1AX, EIF3A, EIF3B, EIF3D, EIF3J, PABPC1, EIF2S2, EIF4A2, UPF3B, EIF4B, TACC3, FMR1, FXR1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14980 | XPO1 | Exportin-1 | 0.799 | Q92769 | HDAC2 | Histone deacetylase 2 | O14980 | XPO1 | Exportin-1 | 0.75 | Q92769 | HDAC2 | Histone deacetylase 2 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.766 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.771 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.72 | Q92769 | HDAC2 | Histone deacetylase 2 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.734 | Q92769 | HDAC2 | Histone deacetylase 2 | P61326 | MAGOH | Protein mago nashi homolog | 0.812 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.729 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.756 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.723 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.883 | Q92769 | HDAC2 | Histone deacetylase 2 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.775 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.708 | Q92769 | HDAC2 | Histone deacetylase 2 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.729 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.725 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.736 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P68104 | EEF1A1 | Elongation factor 1-alpha 1 | 0.848 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P47813 | EIF1AX | Eukaryotic translation initiation factor 1A, X-chromosomal | 0.844 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.869 | Q92769 | HDAC2 | Histone deacetylase 2 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.719 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.731 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | O15371 | EIF3D | Eukaryotic translation initiation factor 3 subunit D | 0.782 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O15371 | EIF3D | Eukaryotic translation initiation factor 3 subunit D | 0.77 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.77 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P11940 | PABPC1 | Polyadenylate-binding protein 1 | 0.767 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.733 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.849 | Q92769 | HDAC2 | Histone deacetylase 2 | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | 0.79 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q9BZI7 | UPF3B | Regulator of nonsense transcripts 3B | 0.764 | Q92769 | HDAC2 | Histone deacetylase 2 | P23588 | EIF4B | Eukaryotic translation initiation factor 4B | 0.767 | Q92769 | HDAC2 | Histone deacetylase 2 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.758 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | Q06787 | FMR1 | Synaptic functional regulator FMR1 | 0.863 | Q96EB6 | SIRT1 | NAD-dependent protein deacetylase sirtuin-1 | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | 0.798 |
| Bilastine | hsa03020 | RNA polymerase | 2.86E-05 | 4 | P24928, P62487, Q9GZM3, P52435 | POLR2A, POLR2G, POLR2J2, POLR2J | More | | Bilastine | hsa03022 | Basal transcription factors | 2.97E-03 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Bilastine | hsa03040 | Spliceosome | 3.58E-06 | 14 | Q14562, O43143, O60508, P17844, P08579, Q15427, P51991, P38159, P61978, Q07955, Q01130, Q13243, P11142, Q9Y2W2 | DHX8, DHX15, CDC40, DDX5, SNRPB2, SF3B4, HNRPA3, RBMX, HNRPK, SFRS1, SFRS2, SFRS5, HSPA8, WBP11 | More | | Bilastine | hsa03050 | Proteasome | 3.05E-02 | 1 | P55036 | PSMD4 | More | | Bilastine | hsa03060 | Protein export | 1.30E-03 | 4 | Q15070, P37108, O76094, Q15005 | OXA1L, SRP14, SRP72, SPCS2 | More | | Bilastine | hsa04012 | ErbB signaling pathway | 3.74E-02 | 3 | P21860, Q13557, O14944 | ERBB3, CAMK2D, EREG | More | | Bilastine | hsa04014 | Ras signaling pathway | 2.54E-02 | 5 | P42338, P20827, P49767, Q13009, P50151 | PIK3CB, EFNA1, VEGFC, TIAM1, GNG10 | More | | Bilastine | hsa04020 | Calcium signaling pathway | 6.50E-04 | 6 | Q96DU7, P45880, Q13557, P21860, P51828, P23634 | ITPKC, VDAC2, CAMK2D, ERBB3, ADCY7, ATP2B4 | More | | Bilastine | hsa04022 | cGMP-PKG signaling pathway | 3.25E-03 | 8 | Q99941, P18848, P23634, Q8WYR1, P51828, P05141, P45880, P0DP24 | CREBL1, ATF4, ATP2B4, PIK3R5, ADCY7, SLC25A5, VDAC2, CALM2 | More | | Bilastine | hsa04024 | cAMP signaling pathway | 4.38E-02 | 4 | P42338, P0DP23, Q13370, Q13009 | PIK3CB, CALM1, PDE3B, TIAM1 | More | | Bilastine | hsa04060 | Cytokine-cytokine receptor interaction | 2.61E-02 | 10 | P27930, P08476, P25024, P25025, Q9UBD3, P47992, P01375, P09341, P18510, Q93038 | IL1R2, INHBA, CXCR1, CXCR2, XCL2, XCL1, TNF, CXCL1, IL1RN, TNFRSF25 | More | | Bilastine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.33E-03 | 8 | P09341, P19875, P25024, P25025, P47992, Q9UBD3, P14784, P01375 | CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL2RB, TNF | More | | Bilastine | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Bilastine | hsa04064 | NF-kappa B signaling pathway | 2.11E-05 | 16 | P10415, O00463, P14778, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q8WV28, Q13315, P24522, P09341, P19875, Q06643 | BCL2, TRAF5, IL1R1, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, BLNK, ATM, GADD45A, CXCL1, CXCL2, LTB | More | | Bilastine | hsa04070 | Phosphatidylinositol signaling system | 4.86E-02 | 3 | P0DP23, P42338, P27987 | CALM1, PIK3CB, ITPKB | More | | Bilastine | hsa04071 | Sphingolipid signaling pathway | 4.52E-05 | 9 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415, Q9UQC2 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2 | More | | Bilastine | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Bilastine | hsa04080 | Neuroactive ligand-receptor interaction | 4.80E-04 | 8 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, ADRB2 | More | | Bilastine | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Bilastine | hsa04120 | Ubiquitin mediated proteolysis | 1.08E-03 | 6 | Q9UBT2, Q14145, Q13042, P62837, Q15751, Q14669 | SAE2, KEAP1, CDC16, UBE2D2, HERC1, TRIP12 | More | | Bilastine | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Bilastine | hsa04140 | Autophagy - animal | 6.25E-03 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Bilastine | hsa04141 | Protein processing in endoplasmic reticulum | 8.43E-06 | 10 | P18848, Q12933, Q15437, Q15436, Q99941, O75460, P11142, Q9H3Z4, P07900, Q9NR31 | ATF4, TRAF2, SEC23B, SEC23A, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | | Bilastine | hsa04142 | Lysosome | 2.64E-02 | 2 | Q99437, P25774 | ATP6V0B, CTSS | More | | Bilastine | hsa04145 | Phagosome | 2.04E-03 | 10 | O75015, Q15080, Q13488, Q99437, P05164, P78380, O60603, P35443, P13765, P25774 | FCGR3B, NCF4, TCIRG1, ATP6V0B, MPO, OLR1, TLR2, THBS4, HLA-DOB, CTSS | More | | Bilastine | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | | Bilastine | hsa04151 | PI3K-Akt signaling pathway | 5.44E-08 | 19 | P62753, P42338, P43657, O43521, P27348, P20827, P49767, P07900, Q8WYR1, P50151, O15335, Q16363, Q13751, P22105, P14784, Q99941, P18848, O00141, Q6ZUJ8 | RPS6, PIK3CB, P2RY5, BCL2L11, YWHAQ, EFNA1, VEGFC, HSP90AA1, PIK3R5, GNG10, CHAD, LAMA4, LAMB3, TNXB, IL2RB, CREBL1, ATF4, SGK, PIK3AP1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P62753 | RPS6 | 40S ribosomal protein S6 | 0.722 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.716 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.709 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.813 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.784 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.724 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P27348 | YWHAQ | 14-3-3 protein theta | 0.833 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P27348 | YWHAQ | 14-3-3 protein theta | 0.742 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P27348 | YWHAQ | 14-3-3 protein theta | 0.708 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P20827 | EFNA1 | Ephrin-A1 | -0.763 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.711 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.786 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.76 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.838 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | O15335 | CHAD | Chondroadherin | -0.792 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q16363 | LAMA4 | Laminin subunit alpha-4 | 0.729 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.805 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P22105 | TNXB | Tenascin-X | 0.777 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P22105 | TNXB | Tenascin-X | 0.72 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.779 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.777 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.72 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.783 | Q86Z02 | HIPK1 | Homeodomain-interacting protein kinase 1 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.773 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.709 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.755 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.728 |
| Bilastine | hsa04210 | Apoptosis | 4.66E-03 | 7 | O76075, P01375, Q9NR28, O75460, Q16548, O43521, P18848 | DFFB, TNF, DIABLO, ERN1, BCL2A1, BCL2L11, ATF4 | More | | Bilastine | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Bilastine | hsa04213 | Longevity regulating pathway - multiple species | 3.85E-02 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Bilastine | hsa04217 | Necroptosis | 2.04E-05 | 12 | P01375, Q12933, P48023, Q14765, P07900, P15104, P05141, P01584, P0C0S5, Q99878, Q13557, Q9H444 | TNF, TRAF2, FASLG, STAT4, HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC14, CAMK2D, CHMP4B | More | | Bilastine | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.68E-03 | 5 | P51828, Q99941, P18848, Q13557, P23634 | ADCY7, CREBL1, ATF4, CAMK2D, ATP2B4 | More | | Bilastine | hsa04270 | Vascular smooth muscle contraction | 2.89E-02 | 2 | P35579, P35318 | MYH9, ADM | More | | Bilastine | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Bilastine | hsa04340 | Hedgehog signaling pathway | 1.36E-04 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Bilastine | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Bilastine | hsa04360 | Axon guidance | 1.71E-02 | 4 | P20827, O95631, P42338, P23528 | EFNA1, NTN1, PIK3CB, CFL1 | More | | Bilastine | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Bilastine | hsa04512 | ECM-receptor interaction | 1.90E-02 | 2 | P26012, P16070 | ITGB8, CD44 | More | | Bilastine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Bilastine | hsa04540 | Gap junction | 2.86E-02 | 3 | P22694, P68371, Q14643 | PRKACB, TUBB2C, ITPR1 | More | | Bilastine | hsa04610 | Complement and coagulation cascades | 5.27E-04 | 4 | P25116, P09871, P0C0L4, Q16581 | F2R, C1S, C4A, C3AR1 | More | | Bilastine | hsa04612 | Antigen processing and presentation | 2.09E-04 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Bilastine | hsa04613 | Neutrophil extracellular trap formation | 1.39E-07 | 23 | P17252, P11215, O60603, P05164, P08246, Q9UM07, Q13547, P04908, Q6FI13, Q93077, P62807, Q16778, O60814, P68431, Q15080, P20160, P08311, P49913, O75015, P21730, P21462, O43315, Q16539 | PRKCA, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q15722 | LTB4R | Leukotriene B4 receptor 1 | P17252 | PRKCA | Protein kinase C alpha type | -0.757 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P11215 | ITGAM | Integrin alpha-M | 0.734 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.942 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P05164 | MPO | Myeloperoxidase | -0.876 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P05164 | MPO | Myeloperoxidase | 0.805 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P08246 | ELA2 | Neutrophil elastase | -0.797 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.846 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | -0.91 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.9 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.799 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | Q13547 | HDAC1 | Histone deacetylase 1 | 0.786 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.74 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.833 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.753 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.753 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | Q16778 | HIST2H2BE | Histone H2B type 2-E | -0.704 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.793 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.869 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.918 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P20160 | AZU1 | Azurocidin | -0.853 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20160 | AZU1 | Azurocidin | 0.734 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P08311 | CTSG | Cathepsin G | -0.866 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08311 | CTSG | Cathepsin G | 0.79 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P49913 | CAMP | Cathelicidin antimicrobial peptide | -0.736 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.766 | P14780 | MMP9 | Matrix metalloproteinase-9 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.928 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.737 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | -0.823 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.942 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.875 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P21462 | FPR1 | fMet-Leu-Phe receptor | -0.716 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.912 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.888 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P14780 | MMP9 | Matrix metalloproteinase-9 | O43315 | AQP9 | Aquaporin-9 | 0.837 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O43315 | AQP9 | Aquaporin-9 | 0.79 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.721 |
| Bilastine | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Bilastine | hsa04621 | NOD-like receptor signaling pathway | 2.50E-03 | 12 | Q16539, Q14643, P21796, P10599, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P09341, P12838 | MAPK14, ITPR1, VDAC1, TXN, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CXCL1, DEFA4 | More | | Bilastine | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Bilastine | hsa04640 | Hematopoietic cell lineage | 4.78E-04 | 14 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF | More | | Bilastine | hsa04650 | Natural killer cell mediated cytotoxicity | 1.22E-07 | 13 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P01375 | TNF | Tumor necrosis factor | -0.856 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | P01375 | TNF | Tumor necrosis factor | -0.72 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | P78314 | SH3BP2 | SH3 domain-binding protein 2 | -0.731 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.812 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.734 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.734 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.85 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.772 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.824 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.83 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.922 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.766 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.879 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.8 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.783 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.8 | O75475 | PSIP1 | PC4 and SFRS1-interacting protein | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.783 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 |
| Bilastine | hsa04657 | IL-17 signaling pathway | 3.42E-06 | 9 | P07900, O00463, Q12933, Q16539, P49841, P09341, P14780, P80188, P01375 | HSP90AA1, TRAF5, TRAF2, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Bilastine | hsa04658 | Th1 and Th2 cell differentiation | 2.61E-07 | 13 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Bilastine | hsa04659 | Th17 cell differentiation | 1.99E-05 | 15 | Q04759, P19174, P06239, P42224, P14784, P13765, P14778, Q9HBE5, P40189, Q9UL17, P23771, P08238, P07766, P09693, P20963 | PRKCQ, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, IL6ST, TBX21, GATA3, HSP90AB1, CD3E, CD3G, CD247 | More | | Bilastine | hsa04660 | T cell receptor signaling pathway | 8.96E-07 | 15 | P01375, Q9UDY8, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.767 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P14780 | MMP9 | Matrix metalloproteinase-9 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.792 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.925 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 1 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.793 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.811 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P14780 | MMP9 | Matrix metalloproteinase-9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.75 |
| Bilastine | hsa04662 | B cell receptor signaling pathway | 9.78E-04 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Bilastine | hsa04664 | Fc epsilon RI signaling pathway | 8.26E-05 | 7 | P01375, Q16539, P42338, Q9UQC2, P07948, P09917, P20292 | TNF, MAPK14, PIK3CB, GAB2, LYN, ALOX5, ALOX5AP | More | | Bilastine | hsa04666 | Fc gamma R-mediated phagocytosis | 3.08E-02 | 3 | P42338, P23528, P14598 | PIK3CB, CFL1, NCF1 | More | | Bilastine | hsa04668 | TNF signaling pathway | 1.16E-05 | 11 | P01375, Q12933, O00463, Q16539, Q99941, P18848, P01584, P20749, P14780, P20333, O95429 | TNF, TRAF2, TRAF5, MAPK14, CREBL1, ATF4, IL1B, BCL3, MMP9, TNFRSF1B, BAG4 | More | | Bilastine | hsa04714 | Thermogenesis | 2.56E-05 | 9 | Q16539, P51828, Q92922, P62753, P33121, P12074, O15239, Q16718, O14521 | MAPK14, ADCY7, SMARCC1, RPS6, ACSL1, COX6A1, NDUFA1, NDUFA5, SDHD | More | | Bilastine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Bilastine | hsa04723 | Retrograde endocannabinoid signaling | 1.75E-02 | 5 | Q14643, P17252, P22694, Q16539, Q16718 | ITPR1, PRKCA, PRKACB, MAPK14, NDUFA5 | More | | Bilastine | hsa04724 | Glutamatergic synapse | 3.24E-02 | 3 | P43003, P50151, P15104 | SLC1A3, GNG10, GLUL | More | | Bilastine | hsa04725 | Cholinergic synapse | 2.22E-03 | 6 | P51828, P22694, Q14643, P18848, Q13557, P10415 | ADCY7, PRKACB, ITPR1, ATF4, CAMK2D, BCL2 | More | | Bilastine | hsa04728 | Dopaminergic synapse | 4.72E-03 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Bilastine | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.62E-04 | 8 | P14778, P01584, P51828, Q13557, P19174, P42338, P24723, Q04759 | IL1R1, IL1B, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Bilastine | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Bilastine | hsa04911 | Insulin secretion | 2.96E-07 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Bilastine | hsa04912 | GnRH signaling pathway | 6.52E-04 | 8 | P17252, P51828, P18848, Q13557, Q16539, Q9Y6R4, Q14643, P22694 | PRKCA, ADCY7, ATF4, CAMK2D, MAPK14, MAP3K4, ITPR1, PRKACB | More | | Bilastine | hsa04913 | Ovarian steroidogenesis | 2.72E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Bilastine | hsa04914 | Progesterone-mediated oocyte maturation | 3.92E-02 | 3 | P42338, Q13370, P08238 | PIK3CB, PDE3B, HSP90AB1 | More | | Bilastine | hsa04915 | Estrogen signaling pathway | 5.03E-04 | 5 | Q99941, P18848, P51828, P07900, P11142 | CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8 | More | | Bilastine | hsa04918 | Thyroid hormone synthesis | 6.57E-05 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Bilastine | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Bilastine | hsa04922 | Glucagon signaling pathway | 4.18E-02 | 2 | P14618, P06737 | PKM2, PYGL | More | | Bilastine | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Bilastine | hsa04924 | Renin secretion | 2.65E-04 | 5 | P22694, P07550, Q14643, Q13370, P0DP23 | PRKACB, ADRB2, ITPR1, PDE3B, CALM1 | More | | Bilastine | hsa04925 | Aldosterone synthesis and secretion | 1.05E-06 | 5 | Q99941, P18848, P51828, Q13557, P23634 | CREBL1, ATF4, ADCY7, CAMK2D, ATP2B4 | More | | Bilastine | hsa04926 | Relaxin signaling pathway | 3.34E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Bilastine | hsa04927 | Cortisol synthesis and secretion | 3.85E-05 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | | Bilastine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.20E-04 | 8 | Q14643, P51828, P22694, P23771, P17252, Q99941, P18848, P10415 | ITPR1, ADCY7, PRKACB, GATA3, PRKCA, CREBL1, ATF4, BCL2 | More | | Bilastine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Bilastine | hsa04932 | Non-alcoholic fatty liver disease | 1.52E-05 | 10 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, Q16718, O14521 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, NDUFA5, SDHD | More | | Bilastine | hsa04934 | Cushing syndrome | 9.25E-09 | 8 | Q14643, Q99941, P18848, P51828, P22694, O15169, Q13557, P04628 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB, AXIN1, CAMK2D, WNT1 | More | | Bilastine | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Bilastine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Bilastine | hsa04962 | Vasopressin-regulated water reabsorption | 7.22E-03 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | | Bilastine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Bilastine | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Bilastine | hsa04970 | Salivary secretion | 2.11E-02 | 3 | P07550, P22694, Q14643 | ADRB2, PRKACB, ITPR1 | More | | Bilastine | hsa04971 | Gastric acid secretion | 1.48E-02 | 3 | P51828, P15311, Q13557 | ADCY7, VIL2, CAMK2D | More | | Bilastine | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Bilastine | hsa04976 | Bile secretion | 1.67E-03 | 3 | O43315, P22694, P08183 | AQP9, PRKACB, ABCB1 | More | | Bilastine | hsa05010 | Alzheimer disease | 1.70E-03 | 11 | Q92542, P05496, P13073, P12074, O75460, P0DP24, P01584, P18848, O15169, P05141, P45880 | NCSTN, ATP5G1, COX4I1, COX6A1, ERN1, CALM2, IL1B, ATF4, AXIN1, SLC25A5, VDAC2 | More | | Bilastine | hsa05012 | Parkinson disease | 3.89E-02 | 5 | P13073, P05141, O75460, P18848, P0DP24 | COX4I1, SLC25A5, ERN1, ATF4, CALM2 | More | | Bilastine | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Bilastine | hsa05016 | Huntington disease | 1.46E-03 | 8 | P13073, Q9GZM3, P24928, P62487, P52435, P05141, O75460, P55036 | COX4I1, POLR2J2, POLR2A, POLR2G, POLR2J, SLC25A5, ERN1, PSMD4 | More | | Bilastine | hsa05020 | Prion disease | 1.37E-03 | 11 | P01584, P46531, P11142, Q16718, O14521, P05496, P12074, P45880, P49841, Q99941, Q16539 | IL1B, NOTCH1, HSPA8, NDUFA5, SDHD, ATP5G1, COX6A1, VDAC2, GSK3B, CREBL1, MAPK14 | More | | Bilastine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 6.94E-04 | 13 | P49841, Q16718, O14521, P13073, O75460, P18848, Q13561, P05141, P20333, Q16539, P01584, Q08752, P0DP24 | GSK3B, NDUFA5, SDHD, COX4I1, ERN1, ATF4, DCTN2, SLC25A5, TNFRSF1B, MAPK14, IL1B, PPID, CALM2 | More | | Bilastine | hsa05030 | Cocaine addiction | 4.39E-03 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Bilastine | hsa05031 | Amphetamine addiction | 8.06E-05 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Bilastine | hsa05034 | Alcoholism | 3.11E-05 | 6 | Q96RR4, Q93077, P62807, O60814, P84243, P68431 | CAMKK2, HIST1H2AC, HIST1H2BC, H2BC12, H3F3A, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Bilastine | hsa05110 | Vibrio cholerae infection | 4.78E-02 | 1 | Q99437 | ATP6V0B | More | | Bilastine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.96E-04 | 6 | Q16539, P09341, P19875, P19174, P25024, P25025 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Bilastine | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Bilastine | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Bilastine | hsa05140 | Leishmaniasis | 1.57E-04 | 8 | P13612, O75015, P13765, O60603, P01375, P49006, Q16539, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MARCKSL1, MAPK14, NCF4 | More | | Bilastine | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Bilastine | hsa05144 | Malaria | 1.53E-03 | 7 | P60033, P69905, P68871, O60603, P01375, P35443, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, KLRK1 | More | | Bilastine | hsa05146 | Amoebiasis | 4.19E-08 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Bilastine | hsa05150 | Staphylococcus aureus infection | 1.91E-04 | 8 | P21730, P21462, O75015, Q14532, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Bilastine | hsa05152 | Tuberculosis | 1.10E-02 | 10 | Q13488, Q99437, O75015, P48382, O60603, P10415, P13765, P25774, Q9UDY8, Q16539 | TCIRG1, ATP6V0B, FCGR3B, RFX5, TLR2, BCL2, HLA-DOB, CTSS, MALT1, MAPK14 | More | | Bilastine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Bilastine | hsa05161 | Hepatitis B | 2.31E-03 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Bilastine | hsa05163 | Human cytomegalovirus infection | 4.62E-04 | 10 | P01375, P63218, P50151, Q14643, P49841, P14778, P25025, Q16539, P04637, O00463 | TNF, GNG5, GNG10, ITPR1, GSK3B, IL1R1, CXCR2, MAPK14, TP53, TRAF5 | More | | Bilastine | hsa05168 | Herpes simplex virus 1 infection | 1.15E-02 | 8 | P42224, Q07955, Q01130, Q13243, P42338, Q13398, Q03923, Q9UDV6 | STAT1, SFRS1, SFRS2, SFRS5, PIK3CB, ZNF211, ZNF85, ZNF212 | More | | Bilastine | hsa05171 | Coronavirus disease - COVID-19 | 1.51E-03 | 8 | P62753, P25398, P36578, P32969, P46776, P62899, P18077, P61927 | RPS6, RPS12, RPL4, RPL9, RPL27A, RPL31, RPL35A, RPL37 | More | | Bilastine | hsa05200 | Pathways in cancer | 3.92E-02 | 9 | P42338, P08238, P42224, P43246, P14923, O75293, P0DP23, P14784, P40189 | PIK3CB, HSP90AB1, STAT1, MSH2, JUP, GADD45B, CALM1, IL2RB, IL6ST | More | | Bilastine | hsa05202 | Transcriptional misregulation in cancer | 3.70E-06 | 20 | Q12778, Q15532, Q13315, P41732, P14780, P27930, Q15744, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, P12980, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q12778 | FOXO1 | Forkhead box protein O1 | -0.769 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q15532 | SS18 | Protein SSXT | -0.803 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P41732 | TSPAN7 | Tetraspanin-7 | 0.775 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.901 | P14780 | MMP9 | Matrix metalloproteinase-9 | P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.861 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.855 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.837 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.734 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.808 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.833 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.783 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.921 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.837 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.797 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | O15550 | UTX | Lysine-specific demethylase 6A | 0.789 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.779 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P05164 | MPO | Myeloperoxidase | -0.876 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P05164 | MPO | Myeloperoxidase | 0.805 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P05164 | MPO | Myeloperoxidase | -0.811 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P12838 | DEFA4 | Neutrophil defensin 4 | -0.871 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P12838 | DEFA4 | Neutrophil defensin 4 | -0.86 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P08246 | ELA2 | Neutrophil elastase | -0.797 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.846 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P08246 | ELA2 | Neutrophil elastase | -0.782 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.726 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.752 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.808 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.9 | P14780 | MMP9 | Matrix metalloproteinase-9 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.812 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | Q13547 | HDAC1 | Histone deacetylase 1 | 0.786 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12980 | LYL1 | Protein lyl-1 | 0.716 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P14780 | MMP9 | Matrix metalloproteinase-9 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.765 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.764 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 |
| Bilastine | hsa05203 | Viral carcinogenesis | 9.94E-06 | 8 | Q12933, Q99941, P18848, P27348, Q15283, P61978, P62807, O60814 | TRAF2, CREBL1, ATF4, YWHAQ, RASA2, HNRPK, HIST1H2BC, H2BC12 | More | | Bilastine | hsa05204 | Chemical carcinogenesis | 1.13E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Bilastine | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Bilastine | hsa05212 | Pancreatic cancer | 2.84E-03 | 4 | P42338, P42224, P37173, O75293 | PIK3CB, STAT1, TGFBR2, GADD45B | More | | Bilastine | hsa05214 | Glioma | 1.72E-02 | 3 | P0DP23, P42338, O75293 | CALM1, PIK3CB, GADD45B | More | | Bilastine | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Bilastine | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Bilastine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.15E-03 | 11 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, O60603, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14, CD4 | More | | Bilastine | hsa05310 | Asthma | 9.08E-04 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Bilastine | hsa05321 | Inflammatory bowel disease | 1.35E-08 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Bilastine | hsa05322 | Systemic lupus erythematosus | 7.11E-07 | 6 | P09871, P29965, Q93077, P62807, O60814, P68431 | C1S, CD40LG, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Bilastine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Bilastine | hsa05332 | Graft-versus-host disease | 1.13E-06 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Bilastine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Bilastine | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | | Bilastine | hsa05418 | Fluid shear stress and atherosclerosis | 1.56E-05 | 12 | Q16539, P42338, Q14145, P14598, P10599, P14780, P01375, P04637, P14778, P27930, P0DP23, P08238 | MAPK14, PIK3CB, KEAP1, NCF1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2, CALM1, HSP90AB1 | More | | |